Kinetics of atrial and brain natriuretic peptides during hemodialysis are regulated in association with different cardiac functional changes

[1]  Haruo M D Nakamura,et al.  Long-term administration of tolvaptan ameliorates annual decline in estimated glomerular filtration rate in outpatients with chronic heart failure , 2021, Heart and Vessels.

[2]  K. Nakao,et al.  The Effects of Super-Flux (High Performance) Dialyzer on Plasma Glycosylated Pro-B-Type Natriuretic Peptide (proBNP) and Glycosylated N-Terminal proBNP in End-Stage Renal Disease Patients on Dialysis , 2013, BMC Pharmacology and Toxicology.

[3]  N. Morgenthaler,et al.  Midregional proadrenomedullin reflects cardiac dysfunction in haemodialysis patients with cardiovascular disease. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  I. Barna,et al.  Atrial natriuretic peptide (ANP) in patients with chronic renal failure on maintenance haemodialysis , 2006, International Urology and Nephrology.

[5]  Satoko Nakamura,et al.  Adrenomedullin reflects cardiac dysfunction, excessive blood volume, and inflammation in hemodialysis patients. , 2005, Kidney international.

[6]  Satoko Nakamura,et al.  Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  T. Inenaga,et al.  Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  N. Kobayashi,et al.  Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  R. Mehta,et al.  Assessment of dry weight in hemodialysis: an overview. , 1999, Journal of the American Society of Nephrology : JASN.

[10]  G. Sagnella.  Measurement and significance of circulating natriuretic peptides in cardiovascular disease. , 1998, Clinical science.

[11]  K. Nitta,et al.  Plasma Concentration of Brain Natriuretic Peptide as an Indicator of Cardiac Ventricular Function in Patients on Hemodialysis , 1998, American Journal of Nephrology.

[12]  H. Makino,et al.  Plasma concentrations of natriuretic peptides in patients on hemodialysis. , 1996, Research communications in molecular pathology and pharmacology.

[13]  K. Miyatake,et al.  Changes of plasma atrial and brain natriuretic peptide levels during hemodialysis. , 1996, Renal failure.

[14]  R. Walker,et al.  Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. , 1994, Clinical science.

[15]  N. Minamino,et al.  Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[17]  A. Grünert,et al.  Changes in brain natriuretic peptide and atrial natriuretic peptide plasma concentrations during hemodialysis in patients with chronic renal failure. , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  T. Horio,et al.  Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. , 1993, American heart journal.

[19]  K. Kohse,et al.  Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. , 1993, Clinical nephrology.

[20]  T. Takagi,et al.  Changes in plasma atrial natriuretic peptide during hemodialysis: mechanism of elevated levels in patients with chronic renal failure. , 1993, Endocrine journal.

[21]  N. Markandu,et al.  Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. , 1992, Clinical science.

[22]  J. Hegbrant,et al.  Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia. , 1992, ASAIO journal.

[23]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[24]  B. Grabensee,et al.  Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis , 1991, Journal of internal medicine.

[25]  H. Koide,et al.  Plasma atrial natriuretic peptide during hemodialysis with or without fluid removal. , 1990, Nephron.

[26]  P. Weidmann,et al.  Plasma levels and dialysance of atrial natriuretic peptide in terminal renal failure. , 1987, Kidney international.

[27]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.